Healmusz Numbing

Description

No description information is available for the specified drug.

Uses and Indications

This drug is indicated for the temporary relief of pain and itching associated with minor burns, sunburn, insect bites, scrapes, and minor skin irritations.

Limitations of Use: This product is intended for external use only and should not be applied to large areas of the body or on deep puncture wounds, animal bites, or serious burns.

Dosage and Administration

Healthcare professionals should begin by cleansing the targeted skin area thoroughly and patting it dry before application. A thin layer of the medication should then be applied to the affected area. This application may be performed up to 3 to 4 times daily, ensuring that the total daily applications do not exceed this frequency. Care should be taken to avoid applying more than the recommended amount to prevent potential adverse effects.

Contraindications

Use is contraindicated on large areas of the body due to the potential for systemic absorption and adverse effects. Application on broken, blistered, or abraded skin is also contraindicated, as this may lead to increased absorption and risk of toxicity. Additionally, the product should not be used in individuals with a known allergy to local anesthetics, including lidocaine, benzocaine, or other "caine" derivatives, due to the risk of severe allergic reactions.

Warnings and Precautions

For external use only. It is imperative that healthcare professionals advise patients to adhere strictly to this guideline to prevent any adverse effects associated with inappropriate use.

In the event of accidental ingestion, immediate medical assistance should be sought. Patients should be instructed to contact a poison control center or seek emergency medical help without delay.

Healthcare providers should monitor patients closely and recommend discontinuation of use if any of the following conditions arise: if the patient's condition worsens or fails to improve within 7 days, if an allergic reaction occurs to any of the product's ingredients, or if the symptoms being treated do not subside. Additionally, if any redness or irritation develops, patients should be advised to stop using the product and consult their healthcare provider.

Side Effects

For external use only. Patients should discontinue use and consult a healthcare professional if the condition worsens or does not improve within 7 days. Additionally, an allergic reaction to any ingredients in this product warrants immediate cessation of use and medical advice. If the symptoms being treated do not subside, or if redness or irritation occurs, patients are advised to seek medical attention.

Drug Interactions

There are currently no documented drug interactions associated with this medication. Additionally, there is no information available regarding interactions with laboratory tests. As such, no specific recommendations for dosage adjustments or monitoring are warranted at this time.

Packaging & NDC

Below are the non-prescription pack sizes of Healmusz Numbing (menthol 5% numbing). Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Pediatric Use

Pediatric patients should be advised to keep this medication out of reach of children. In the event of accidental ingestion, immediate medical assistance should be sought, or a poison control center should be contacted without delay.

Geriatric Use

Elderly patients may not have specific information regarding the use of this medication, including dosage adjustments, safety concerns, or special precautions. Therefore, healthcare providers should exercise caution when prescribing this medication to geriatric patients. It is advisable to monitor these patients closely for any adverse effects or changes in therapeutic response, given the lack of targeted data for this population.

Pregnancy

The available prescribing information does not provide specific data regarding the use of this product during pregnancy. There are no contraindications noted for use in pregnant patients, nor are there any associated risks to the fetus identified in the available literature. Additionally, no dosage modifications or special precautions for use during pregnancy are mentioned. Healthcare professionals should consider the lack of data when prescribing this product to women of childbearing potential and weigh the potential benefits against any unknown risks.

Lactation

There are no specific warnings or recommendations regarding the use of this product in lactating mothers. Additionally, there are no statements concerning the potential for excretion in breast milk or any associated risks to breastfed infants.

Renal Impairment

Patients with renal impairment have not been specifically addressed in the available prescribing information. There are no dosage adjustments, special monitoring requirements, or safety considerations outlined for individuals with reduced kidney function. Healthcare professionals should exercise caution and consider the lack of data when prescribing to this patient population.

Hepatic Impairment

Patients with hepatic impairment have not been specifically studied in relation to the use of this medication. Consequently, there are no established dosage adjustments, special monitoring requirements, or precautions outlined for individuals with compromised liver function. It is recommended that healthcare providers exercise caution when prescribing this medication to patients with hepatic impairment, given the lack of data on its safety and efficacy in this population. Regular monitoring of liver function may be prudent in these cases, although specific parameters are not defined in the available information.

Overdosage

There is currently no specific information available regarding overdosage for this medication. Healthcare professionals are advised to monitor patients closely for any signs of adverse effects or symptoms that may arise from excessive dosing.

In the event of suspected overdosage, it is recommended that healthcare providers initiate supportive care and symptomatic treatment as necessary. Patients should be evaluated for potential complications, and appropriate interventions should be implemented based on clinical judgment.

For further guidance, healthcare professionals may refer to established protocols for managing drug overdosage or consult a poison control center.

Nonclinical Toxicology

No teratogenic or non-teratogenic effects have been reported in the available nonclinical studies. Additionally, there is no information regarding animal pharmacology and toxicology. The absence of data limits the assessment of potential risks associated with the compound in these areas.

Postmarketing Experience

No postmarketing experience details are available in the insert text.

Patient Counseling

Healthcare providers should advise patients to seek immediate medical assistance or contact a poison control center if the product is swallowed. It is important to instruct patients to avoid applying the product on large areas of the body, broken, blistered, or abraded skin, as this may increase the risk of adverse effects.

Patients should be informed to refrain from using the product if they have a known allergy to local anesthetics, including lidocaine, benzocaine, or other "caine" derivatives. They should be counseled to monitor their condition and report to their healthcare provider if symptoms worsen or do not improve within 7 days of use.

Instruct patients to be vigilant for any signs of an allergic reaction to the ingredients in the product. They should be advised to discontinue use and consult their healthcare provider if the symptom being treated does not subside, or if they experience redness or irritation.

Healthcare providers should emphasize the importance of avoiding contact with the eyes and advise patients not to bandage the area tightly or use the product in conjunction with a heating pad. Finally, it is crucial to remind patients to use the product only as directed to ensure safety and efficacy.

Storage and Handling

The product is supplied in various package configurations, with specific NDC numbers available for identification. It should be stored at a temperature range of 15-30°C (59-86°F) to maintain its efficacy. Care must be taken to protect the product from excessive heat and direct sunlight to ensure optimal stability. It is essential to use the product only as directed to ensure safety and effectiveness.

Additional Clinical Information

The medication is administered topically, with a recommended application of a thin layer to the affected area, not exceeding 3-4 times daily. There are no additional details available regarding laboratory tests, abuse information, patient counseling, or postmarketing experience.

Drug Information (PDF)

This file contains official product information for Healmusz Numbing, including active ingredients, dosage, warnings, and labeling as submitted by the manufacturer for OTC distribution.

View product document (PDF)